With limited therapies available to slow disease progression and an aging U.S. population, the number of Parkinson’s disease cases in the United States is expected to rise to 1.2 million by 2030, according to the Parkinson’s Foundation.
While many researchers focus on the disease after it has progressed, Jason Cannon, professor and acting head of the Purdue University School of Health Sciences, and Fatema Currim, a postdoctoral researcher in the Cannon Lab of Experimental and Translational Neurotoxicology, are looking into the first environmental and dietary exposures that influence Parkinson’s disease development.
Written By: Rebecca Hoffa, rhoffa@purdue.edu With limited therapies available to slow disease progression and an aging U.S. population, the number of Parkinson’s disease cases in the United States is expected to rise to 1.2 million by 2030, according to the...